Anaptysbio, Inc (ANAB)

Last Three Months

23-Aug-24 -- 22-Nov-24

Time Period:

Three Months
|
Year

0 Net Amount

Buy:	0	--
Sell:	0	--

Company Sentiment

Other

Other

Insider Trading Sentiment: Sell

Insider Trading Sentiment: Sell

Sentiment Breakdown by Insider

0

(3)

0

(2)

1

(1)

17

0

3

+1

0

+2

0

+3

Two Year Chart

23-Nov-22 -- 22-Nov-24

Price ($)

Two Year Stock Price Chart

Sentiment

Buy & Sell Volume ($)

Two Year Insider Trading Volume Chart

Recent Insider Trades

Last Transaction		Last Three Months
SEC Filing	Transaction	Insider	Sentiment	Company	Holdings Change	Buy Amount	Sell Amount	Buy Price Range	Sell Price Range
17-Sep-24 6:41 PM View:	16-Sep-24 Planned Option Sale ($401.30K)	Mulroy Dennis Chief Financial Officer		Anaptysbio, Inc - ANAB	392% 0.96K to 4.74K	0	0	--	--	Show Txns Hide Txns

24-Sep-24 4:18 PM View:	23-Sep-24 Planned Option Sale ($58.00K)	Lizzul Paul F. Chief Medical Officer		Anaptysbio, Inc - ANAB	33% 11.62K to 15.4K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 6:44 PM View:	17-Sep-24 Sale (Planned) ($57.62K)	Loumeau Eric J Chief Legal Officer		Anaptysbio, Inc - ANAB	(32%) 4.74K to 3.24K	0	0	--	--	Show Txns Hide Txns

17-Sep-24 6:45 PM View:	15-Sep-24 Option Exercise 0	Orwin John A Director		Anaptysbio, Inc - ANAB	64% 2.04K to 3.33K	0	0	--	--	Show Txns Hide Txns